QCACX | VSMPX | QCACX / VSMPX | |
Total Expense Ratio | 1.84 | 0.02 | 9,200% |
Annual Report Gross Expense Ratio | 1.94 | 0.02 | 9,700% |
Fund Existence | 20 years | 10 years | - |
Gain YTD | 10.469 | 6.426 | 163% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1500 | 100000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.16B | 1.82T | 0% |
Annual Yield % from dividends | 0.00 | 1.22 | - |
Returns for 1 year | 11.03 | 13.90 | 79% |
Returns for 3 years | 50.90 | 62.17 | 82% |
Returns for 5 years | 54.59 | 95.69 | 57% |
Returns for 10 years | 109.88 | 189.21 | 58% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GMZPX | 35.44 | 0.40 | +1.14% |
Goldman Sachs Large Cap Gr Insghts P | |||
JLCWX | 74.22 | 0.41 | +0.56% |
JHancock Fundamental Large Cap Core R6 | |||
HIEMX | 8.31 | 0.02 | +0.24% |
Virtus SGA Emerging Markets Equity I | |||
LHCQX | 18.04 | 0.04 | +0.22% |
Lord Abbett Health Care R3 | |||
BNIEX | 11.72 | -0.01 | -0.09% |
UBS International Sustainable Equity A |